Lifeboat Foundation

A Danish company is aiming to build smaller, safe nuclear reactors based on thorium and molten salt, after securing funding in its first pre-seed investment round.

Copenhagen-based Seaborg Technologies, which is developing thorium-based Molten Salt Reactors (MSRs), has received funding from an investment coalition led by Danish innovation incubator PreSeed Ventures.

The company hopes the funding will accelerate development of its CUBE (Compact Used fuel BurnEr) reactor concept.

http://radicalsciencenews.org/the-origin-of-life/

Radical Science News is about radical breakthroughs and the newest technology and ideas that will change the world.

Two historic events happened this past week that will lay the groundwork for the future of American space exploration.

First, after a close vote in the Senate, Rep. Jim Bridenstine, R-Okla. – a former Navy combat pilot – was confirmed as the new head of NASA. I am confident he will be a strong leader in space exploration as we begin a new era of innovation, technological advancement and limitless exploration.

Second, Vice President Mike Pence laid out a bold vision for America’s future in space exploration during his opening remarks at the Space Foundation’s 34^th Annual Space Symposium in Colorado. The vice president showed the Trump administration’s commitment to restoring American leadership in space, rightly pointing out that “we stand at the dawn of a new era of human activity in space; a turning point that will bring new opportunities and new challenges.”

Continue reading “Newt Gingrich: A glimpse of America’s future in space in 2024” »

Artificial intelligence is transforming virtually every industry. Are you ready to benefit from the AI revolution?

https://theglowingskinseries.com/day-15/

The breakthrough is the first time the problem’s answer has been narrowed down since last century.

Science.

The materials innovation startup known for its synthetic spider sillk is rolling out a second bio-material, a leather made from mycelium that can be grown in a small space with a much lower environmental impact than raising cattle.

Jerome Groopman discusses the results of a trial described in the New England Journal of Medicine, in which twenty-two patients with beta thalassemia, a common and devastating blood disorder, were treated with gene therapy.

The biotechnology sector’s fastest-growing segment, immuno-oncology, has become the hottest buzzword for investment in Asia.

The field, that uses the body’s own immune system to help fight cancer, has seen two mega acquisitions in the United States in recent months.

And Hong Kong stock exchange is now tuning into its strong future, with Hong Kong Exchanges and Clearing (HKEX) already agreeing to revamp listing rules that will fast track applications by firms linked with the sector to help more innovative drugs and medical devices developers go public as soon as early this summer, and raise much-needed development cash.

Continue reading “Why immuno-therapy is leaving markets abuzz across the world” »